Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001–2018: a national population-based cohort study

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2023-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-023-04771-6PMID 37061628PMCID PMC11797494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010-2018.

  2022cited by this paper
• Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013

  2022cited by this paper
• Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019

  2021cited by this paper
• The incidence and prevalence of upper tract urothelial carcinoma: a systematic review

  2021cited by this paper
• Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System

  2021cited by this paper
• Accuracy of long-form data in the Taiwan cancer registry.

  2021cited by this paper
• Computational Analysis of Naturally Occurring Aristolochic Acid Analogues and Their Biological Sources

  2021cited by this paper
• Journal of Cancer Research and Clinical Oncology

  2021cited by this paper
• Epidemiology of Bladder Cancer

  2020cited by this paper
• The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis.

  2020cited by this paper
• Taiwan's Nationwide Cancer Registry System of 40 years: Past, present, and future.

  2019cited by this paper
• Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis

  2019cited by this paper
• Development of a database on key characteristics of human carcinogens

  2019cited by this paper
• The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection

  2018cited by this paper
• Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan

  2018cited by this paper
• Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

  2018cited by this paper
• Epidemiology of urothelial carcinoma

  2017influential reference
• Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan

  2017cited by this paper
• The trends of utilization in traditional Chinese medicine in Taiwan from 2000 to 2010

  2016cited by this paper
• The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.

  2016cited by this paper
• Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.

  2016cited by this paper
• Risk assessment of plant food supplements and other herbal products containing aristolochic acids using the margin of exposure (MOE) approach

  2016cited by this paper
• Urothelial carcinoma: Recurrence and risk factors.

  2015cited by this paper
• Chinese Herbs Containing Aristolochic Acid Associated with Renal Failure and Urothelial Carcinoma: A Review from Epidemiologic Observations to Causal Inference

  2014cited by this paper
• Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high-performance liquid chromatography–multistage fragmentation mass spectrometry

  2014cited by this paper
• Increased Upper and Lower Tract Urothelial Carcinoma in Patients with End-Stage Renal Disease: A Nationwide Cohort Study in Taiwan during 1997–2008

  2014cited by this paper
• Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists.

  2013cited by this paper
• Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease

  2013cited by this paper
• Aristolochic acid-associated urothelial cancer in Taiwan

  2012cited by this paper
• Data quality at the Icelandic Cancer Registry: Comparability, validity, timeliness and completeness

  2012cited by this paper
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 99: Some Aromatic Amines, Organic Dyes, and Related Exposures. International Agency for Research on Cancer

  2012cited by this paper
• Association between smoking and risk of bladder cancer among men and women.

  2011cited by this paper
• Gate Wait for Better Air

  2011cited by this paper
• The Beat

  2011cited by this paper
• Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.

  2010cited by this paper
• Background Methods Results

  2009cited by this paper
• Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness.

  2009cited by this paper
• Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract

  2009cited by this paper
• Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan

  2008cited by this paper
• Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003

  2008cited by this paper
• Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.

  2007cited by this paper
• Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow‐up study

  2007cited by this paper
• Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.

  2007cited by this paper
• Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development.

  2007cited by this paper
• Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.

  2005cited by this paper
• Safety of Aristolochic Acid

  2001cited by this paper
• From the Food and Drug Administration.

  2001cited by this paper
• Urothelial malignant disease and Chinese herbal nephropathy.

  2001cited by this paper
• Cancer and herbs.

  2000cited by this paper
• Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

  2000cited by this paper
• Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement.

  1998cited by this paper
• Chlorinated drinking-water; chlorination by-products; some other halogenated compounds; cobalt and cobalt compounds. International Agency for Research on Cancer (IARC) Working Group, Lyon, 12-19 June 1990.

  1991cited by this paper
• A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan.

  1986cited by this paper
• International Classification of Diseases for Oncology

  1977cited by this paper
• UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )

  year unknowncited by this paper

• Elucidating the mechanisms of aristolochic acid-induced upper tract urothelial carcinoma: A multi-omics approach combining bioinformatics and computational modeling.

  2026cites this paper
• Clinical and safety outcomes associated with aristolochic acid exposure: a systematic review and meta-analysis

  2025cites this paper
• Does artificial intelligence redefine nuclear‐to‐cytoplasmic ratio threshold for diagnosing high‐grade urothelial carcinoma?

  2025influential citation
• Endoscopic Thulium Laser Ablation with Disitamab Vedotin and Immunotherapy in High-risk Upper Tract Urothelial Carcinoma: A Prospective Pilot Study of a Novel Kidney-sparing Strategy.

  2025cites this paper
• Distinct molecular signatures of upper tract urothelial carcinoma in Southwestern Taiwan: implications for targeted therapy and disease progression.

  2025cites this paper
• A network toxicology approach to elucidate shared oncogenic pathways of Aristolochic acids in prostate, kidney, and bladder cancers.

  2025cites this paper
• Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan.

  2024cites this paper
• Comprehensive HRMS Screening and Risk Assessments of Aristolochic Acid Analogues in Asari Radix et Rhizoma and Related Commercial Health Products.

  2024cites this paper
• Long-term oral administration of Kelisha capsule does not cause hepatorenal toxicity in rats.

  2024cites this paper
• Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations

  2024cites this paper
• Diagnostic status and new explorations in upper urinary tract urothelial carcinoma: a literature review

  2024cites this paper
• Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review

  2023cites this paper